Progress_of_fibrinolysis_during_tumor_necrosis_factor_infusions_in_humans._Concomitant_increase_in_tissue-type_plasminogen_activator,_plasminogen_activator_inhibitor_type-1,_and_fibrin(ogen)_degradation_products._Several_investigators_have_reported_that_tumor_necrosis_factor_(TNF)_can_alter_the_production_of_plasminogen_activator_type-1_(PAI-1)_and_plasminogen_activators_(PAs)_by_endothelial_cells_in_vitro._We_have_examined_the_in_vivo_effects_of_recombinant_human_TNF_administration_on_fibrinolysis_as_assessed_by_parameters_in_plasma_during_a_24-hour_period_of_continuous_TNF_infusion_to_17_cancer_patients_with_active_disease._The_plasma_levels_of_PAI_activity_increased_sevenfold_after_3_and_24_hours_of_TNF_infusion._This_was_the_result_of_an_increase_of_PAI-1_antigen;_PAI-2_antigen_was_not_detectable._Plasma_concentrations_of_tissue-type_PA_(t-PA)_antigen_increased_twofold_to_fivefold_after_3_and_24_hours_of_TNF_infusion,_whereas_urokinase-type_PA_antigen_levels_in_plasma_remained_unaltered._After_3_hours_of_TNF_infusion_the_plasma_levels_of_alpha_2-antiplasmin_were_slightly_decreased,_5%_on_average,_suggesting_that_fibrinolysis_continued._After_24_hours_of_TNF_infusion_a_highly_significant_increase_in_fibrin-_plus_fibrinogen-degradation_products,_and_separately_of_fibrin_degradation_products_and_fibrinogen_degradation_products,_was_found._This_indicates_that_fibrinolysis_persisted,_at_least_partly,_in_the_presence_of_high_levels_of_PAI_activity._Whereas_PAI-1_production_increased,_t-PA_production_by_human_endothelial_cells_in_vitro_remains_unaltered_or_even_decreases_on_TNF_addition._It_has_been_shown_previously_that_TNF_infusion_in_our_patients_results_in_thrombin_and_fibrin_generation._Therefore,_it_is_possible_that_thrombin,_not_TNF,_is_the_actual_stimulus_for_t-PA_production_in_our_patients._We_speculate_that_fibrin_is_formed_during_TNF_infusions_and_that_plasmin_is_generated_by_t-PA_action_immediately_on_the_initial_formation_of_(soluble)_fibrin_molecules._Such_a_process_may_explain_the_generation_of_degradation_products_of_both_fibrin_and_fibrinogen_during_infusion_of_TNF_in_patients.